These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 33834414)

  • 1. Induced Pluripotent Stem Cells (iPSCs) Technology: Potential Targets for Depression.
    Colpo GD; Teixeira AL
    Adv Exp Med Biol; 2021; 1305():493-501. PubMed ID: 33834414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling psychiatric disorders with patient-derived iPSCs.
    Wen Z; Christian KM; Song H; Ming GL
    Curr Opin Neurobiol; 2016 Feb; 36():118-27. PubMed ID: 26705693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling neurodevelopmental and psychiatric diseases with human iPSCs.
    Wen Z
    J Neurosci Res; 2017 May; 95(5):1097-1109. PubMed ID: 28186671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Derived Induced Pluripotent Stem Cells (iPSCs) and Cerebral Organoids for Drug Screening and Development in Autism Spectrum Disorder: Opportunities and Challenges.
    Villa C; Combi R; Conconi D; Lavitrano M
    Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33669772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonergic neurons derived from induced pluripotent stem cells (iPSCs): a new pathway for research on the biology and pharmacology of major depression.
    Licinio J; Wong ML
    Mol Psychiatry; 2016 Jan; 21(1):1-2. PubMed ID: 26678307
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential Use of Stem Cells in Mood Disorders.
    Colpo GD; Stertz L; Diniz BS; Teixeira AL
    Adv Exp Med Biol; 2018; 1089():87-96. PubMed ID: 30051319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of induced pluripotent stem cell technology for the investigation of hematological disorders.
    Dolatshad H; Tatwavedi D; Ahmed D; Tegethoff JF; Boultwood J; Pellagatti A
    Adv Biol Regul; 2019 Jan; 71():19-33. PubMed ID: 30341008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced Pluripotent Stem Cells and Induced Pluripotent Cancer Cells in Cancer Disease Modeling.
    Zhu D; Kong CSL; Gingold JA; Zhao R; Lee DF
    Adv Exp Med Biol; 2018; 1119():169-183. PubMed ID: 30069853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential applications of induced pluripotent stem cells (iPSCs) in the modeling of gastrointestinal disorders.
    Liu S; Zhang D; Chen Y; Wang B; Qiao L
    Curr Stem Cell Res Ther; 2015; 10(3):220-7. PubMed ID: 25723188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications.
    Das AK; Pal R
    J Tissue Eng Regen Med; 2010 Aug; 4(6):413-21. PubMed ID: 20084623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential therapeutic applications of differentiated induced pluripotent stem cells (iPSCs) in the treatment of neurodegenerative diseases.
    Gao A; Peng Y; Deng Y; Qing H
    Neuroscience; 2013 Jan; 228():47-59. PubMed ID: 23069758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling Psychiatric Diseases with Induced Pluripotent Stem Cells.
    van Hugte E; Nadif Kasri N
    Adv Exp Med Biol; 2019; 1192():297-312. PubMed ID: 31705501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
    Corti S; Faravelli I; Cardano M; Conti L
    Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Induced pluripotent stem cell technology and its application in disease research].
    Cai CY; Meng FL; Rao L; Liu YY; Zhao XL
    Yi Chuan; 2020 Nov; 42(11):1042-1061. PubMed ID: 33229312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human induced pluripotent stem cells technology in treatment resistant depression: novel strategies and opportunities to unravel ketamine's fast-acting antidepressant mechanisms.
    Marcatili M; Sala C; Dakanalis A; Colmegna F; D'Agostino A; Gambini O; Dell'Osso B; Benatti B; Conti L; Clerici M
    Ther Adv Psychopharmacol; 2020; 10():2045125320968331. PubMed ID: 33224469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-Organized Cerebellar Tissue from Human Pluripotent Stem Cells and Disease Modeling with Patient-Derived iPSCs.
    Muguruma K
    Cerebellum; 2018 Feb; 17(1):37-41. PubMed ID: 29196977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced pluripotent stem cell modeling of malignant hematopoiesis.
    Chao MP; Majeti R
    Exp Hematol; 2019 Mar; 71():68-76. PubMed ID: 30659850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerating progress in induced pluripotent stem cell research for neurological diseases.
    Ito D; Okano H; Suzuki N
    Ann Neurol; 2012 Aug; 72(2):167-74. PubMed ID: 22926850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positioning canine induced pluripotent stem cells (iPSCs) in the reprogramming landscape of naïve or primed state in comparison to mouse and human iPSCs.
    Menon DV; Bhaskar S; Sheshadri P; Joshi CG; Patel D; Kumar A
    Life Sci; 2021 Jan; 264():118701. PubMed ID: 33130086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.